Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - ropinirole hydrochloride - film coated tablet - 0.5 milligram

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

smithkline beecham plc - a/singapore 6/86 b/beying /1/87 b/panama/45/90 -

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

smithkline beecham plc - a/singapore 6/86 b/beying /1/87 b/panama/45/90 -

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

smithkline beecham plc - a/singapore 6/86 b/beying /1/87 b/panama/45/90 -

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

smithkline beecham plc - hepatit a virus antigen aluminium hydroxide - suspension for injection

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

smithkline beecham plc - hepatit a virus antigen aluminium hydroxide - suspension for injection

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

smithkline beecham plc - hepatit a virus antigen aluminium hydroxide - suspension for injection

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

smithkline beecham plc - hepatit a virus antigen aluminium hydroxide - suspension for injection

Singapur - inglise - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - live attenuated measles virus (schwarz strain); live attenuated mumps virus (rit4385 strain); live attenuated rubella virus (wistar ra 27/3 strain); live attenuated varicella virus (oka strain) - injection, powder, lyophilized, for solution - ≥ 10 3.0 ccid50 /dose - live attenuated measles virus (schwarz strain) ≥ 10³ ccid50/dose; live attenuated mumps virus (rit4385 strain) ≥ 10⁴·⁴ ccid50/dose; live attenuated rubella virus (wistar ra 27/3 strain) ≥ 10³ ccid50/dose; live attenuated varicella virus (oka strain) ≥ 10³·³ pfu/dose

Singapur - inglise - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - diphtheria toxoid; filamentous haemagglutinin; hepatitis b surface antigen (purified); hib purified capsular polysaccharide bound to tetanus toxoid; pertactin (69 kda omp); pertussis toxoid; poliovirus type 1 (inactivated); poliovirus type 2 (inactivated); poliovirus type 3 (inactivated) - injection - min 30 iu/0.5 ml - diphtheria toxoid min 30 iu/0.5 ml; filamentous haemagglutinin 25 mcg/0.5 ml; hepatitis b surface antigen (purified) 10 mcg/0.5 ml; hib purified capsular polysaccharide bound to tetanus toxoid 10 mcg/0.5 ml; pertactin (69 kda omp) 8 mcg/0.5 ml; pertussis toxoid 25 mcg/0.5 ml; poliovirus type 1 (inactivated) 40 du/0.5 ml; poliovirus type 2 (inactivated) 8 du/0.5 ml; poliovirus type 3 (inactivated) 32 du/0.5 ml